What is Drug Intelligence Reinforce®️ (DIR)?
The drug information database Drug Intelligence Reinforce®️ (DIR) is installed in various systems used by medical institutions, such as electronic medical records, electronic drug histories, and receipt computers. DIR has been installed in approximately 45,000 facilities(*2) nationwide, making it one of the industry's top installations, and it is highly evaluated by many medical professionals and system vendors. In addition, the system is also used for research related to pharmaceuticals at universities and other public institutions.
Drug Intelligence Reinforce®️ (DIR)
1. high reliability
Presence of a team with highly specialized skills such as pharmacists, medical informatics technicians, DB specialists, etc.
2. immediacy of data
Monthly updates of the latest data, with some data distributed in real time.
3. diverse lineup and flexibility
・Holds 55 databases, the largest number in Japan (*3) (as of October 2019)
Ethical drugs: approx. 20,000 items (drugs listed in the NHI Drug Price Standards and drugs not listed in the NHI Drug Price Standards, including vaccines)
OTC drugs: approx. 12,500 products
Combination of databases is possible according to the purpose of use

Results (as of March 31, 2019)
Clinical applications (electronic medical records/electronic drug histories/receipt computers, etc.)
Hospitals: approx. 2,500 facilities
Clinics: approx. 7,500 facilities
Dispensing pharmacies: approx. 35,000 facilities
In addition, we have experience in data analysis, web content, and various research fields.
Background of this program release
The start-up company, which had just been established, had to proceed with service design and mock-up production with a limited budget, making it difficult to purchase actual data at a cost during the testing phase.
As a leading company in the pharmaceutical database industry, Data-Index will support startup companies aiming to create businesses such as web services, smartphone applications, drug information systems, PHRs, and pharmaceutical information analysis services that utilize pharmaceutical information, with the aim of helping new We aim to contribute to people's health through the launch of new medical/healthcare-related services.
Databases covered in this issue
Basic master data such as Drug Master DB, Attachment DB, Original Generic Generic Name Prescription DB, Generic Drug DB, High Risk Candidate Drug DB, Long-term Dosing Restriction DB, and Attachment Data (for ethical drugs only)
*1 Data provision is subject to internal review. Data sales to other companies and other uses beyond the scope of the database terms of use are not covered by this agreement.
*2 As of March 31, 2019
*3 According to our research
| Company Name | Data Index Corporation |
| Establishment | March 9, 1990 |
| address (e.g. of house) | 11F PMO Tamachi, 5-31-17 Shiba, Minato-ku, Tokyo |
| representative director (i.e. someone chosen by the board of directors from among the directors to actually represent the company) | bridge girder |
| Company HP | http://www.data-index.co.jp/ |
| Business | Development, research and sales of drug information database Drug Intelligence Reinforce®️ (abbreviated DIR), development, research and sales of medical information systems |
Distributed by: PR TIMES
PORT Editorial Office PORT" is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies aiming to create new businesses on the theme of social issues, operated by Creww, Inc.






